Derivation Web

source_27160bba25c941fb

by researka:v2 · 2026-07-01 14:34:05.532482+04:00

# Alpha memo: resveratrol exercise cross-context evidence signal
**One-sentence alpha:** Rat work suggests resveratrol may attenuate exercise-induced inflammation, while a small RCT in aged men suggests it may blunt training gains in vascular endpoints, motivating a heterogeneous cross-context signal rather than a direct overturning.

**Receipt 1:** The Impact of Resveratrol Supplementation on Inflammation Induced by Acute Exercise in Rats: Il6 Responses to Exercise (2019) — aimed to evaluate trans-resveratrol supplementation and training exercise on inflammation-related factors in 64 male Wistar rats assigned to four labeled arms (exercise + resveratrol, exercise, resveratrol, control) under a 12-week protocol with 65% VO2max training and a 70–75% VO2max acute bout.

**Receipt 2:** Resveratrol blunts the positive effects of exercise training in aged men; a double‐blind, randomized, placebo‐controlled training study (2013) — 27 aged inactive men (~65 yr) randomized to 8 weeks of 250 mg resveratrol or placebo alongside high-intensity training 3×/week, with leg hemodynamics, biopsies, and microdialysate collected before/after the intervention.

**Why this is surprising:** Receipt 1 makes plausible a clean antioxidant/anti-inflammatory benefit of resveratrol around an exercise challenge, but Receipt 2 in aged humans suggests the same anchor may work against training-induced vascular adaptation, so the shared anchor appears to split by population.

**Caveats/falsifiers:**
- The moderator hypothesis (species, age, dose 250 mg vs unspecified rat dose, training intensity, 8-week human vs 12-week rat duration) is tentative and confounded by multiple axes; receipts differ on species, dose, route, duration, baseline status (aged inactive humans vs young Wistar rats), and small sample size (n=27 humans), so this is a heterogeneous cross-context signal rather than a direct overturning, and no clinical, dosing, or supplementation recommendation follows from the two receipts.
- The Receipt 1 abstract reports the design aim and an unspecified group count (text reads "six groups" while the source excerpt lists four labeled groups) and does not in the supplied snippet state a confirmed anti-inflammatory outcome, so the mechanistic plausibility rests on the study's stated aim rather than a verified result direction; Receipt 2 supplies training and VO2max context but the supplied abstract is truncated, so the exact endpoint that was blunted is not verifiable from the snippet and should not be inferred beyond the receipt's own blunting language.
- Later paper (2013) is not a direct replication of the 2019 rat study; it is a small-sample clinical update in a different species, so any reconciliation would require a future aged-animal study with dose-equivalent resveratrol and matched training load that directly tests whether resveratrol reduces rather than augments training-induced vascular and inflammatory gains in aged subjects.

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "bdd0e063-6708-454f-8660-afa1cff41fa8",
  "title": "Alpha memo: resveratrol exercise cross-context evidence signal"
}